Anticoagulants (Blood Thinners): Uses, Types, and Examples
Anticoagulants inhibit clot formation by targeting coagulation factors. They do not “thin” blood but prevent fibrin formation.
Major Classes & Examples
- Heparins: Unfractionated heparin (IV, rapid, reversible), Low‑molecular‑weight heparin (enoxaparin, dalteparin – SC, predictable).
- Vitamin K Antagonist: Warfarin (oral, requires INR monitoring, diet interactions).
- Direct Oral Anticoagulants (DOACs): Dabigatran (thrombin inhibitor), rivaroxaban, apixaban, edoxaban (factor Xa inhibitors). Fixed dosing, no routine monitoring.
- Antiplatelet (often grouped): Aspirin (COX‑1 inhibitor), clopidogrel, ticagrelor – prevent platelet aggregation, used for arterial thrombosis.
Common Indications
- Atrial fibrillation (stroke prevention)
- Venous thromboembolism (DVT/PE treatment & prevention)
- Mechanical heart valves (warfarin required)
- Post‑orthopedic surgery prophylaxis
- Acute coronary syndrome (antiplatelets ± anticoagulant)
Key Safety Points
- Bleeding risk: assess HAS‑BLED, renal/hepatic function.
- Reversal agents: idarucizumab (dabigatran), andexanet alfa (factor Xa inhibitors), vitamin K/4F‑PCC (warfarin).
- Drug interactions (CYP3A4/P‑gp for DOACs).
- Patient education: signs of bleed, adherence, medical alert ID.
Blood Disorders - Related Articles
- Accidental Wrong-Patient Blood Draw: Immediate Protocol & Documentation
- Water Absorption into Blood: Osmosis, Capillary Dynamics, and Clinical Relevance
- Aplastic Anemia: Severity, Symptoms, and Treatment Options
- Understanding Stage II Multiple Myeloma Treatment Options
- Calf Pain: When to Seek Immediate Medical Care
- AB Blood Type Inheritance: How A + B Parents Can Have an AB Child
- Sickle Cell Disease Prognosis: Understanding the Outlook and Treatment
